Hong Wan
Hefei, 230022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Navitoclax-encapsulated dual pH-responsive copolymeric nanoparticles improves hepatocellular carcinoma treatment with induction of apoptosis and immune activation.
Journal: Journal of nanobiotechnology
Published: January 18, 2026
Exploring the prognostic value of T cell exhaustion and mitochondrial dysfunction related genes in breast cancer through bioinformatics analysis and RT-qPCR validation.
Journal: Clinical and experimental medicine
Published: July 12, 2025
Machine learning and single-cell analysis uncover distinctive characteristics of CD300LG within the TNBC immune microenvironment: experimental validation.
Journal: Clinical and experimental medicine
Published: March 23, 2025
Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer.
Journal: Frontiers in endocrinology
Published: January 13, 2025
Single-cell and transcriptome analyses revealed CTHRC1 a potential therapeutic target mediating invasion and tumor microenvironment in TNBC: experimental validation.
Journal: Frontiers in immunology
Published: November 26, 2024
Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
Journal: Frontiers in immunology
Published: July 14, 2023
PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification.
Journal: Frontiers in immunology
Published: January 16, 2023
Gasless endoscopic thyroidectomy via modified areola approach with a simple flap-lifting technique.
Journal: Frontiers in endocrinology
Published: August 26, 2022
Long noncoding RNA 02027 inhibits proliferation, migration and invasion of hepatocellular carcinoma via miR-625-3p/PDLIM5 pathway.
Journal: The journal of gene medicine
Published: February 14, 2022
Last Updated: 09/26/2026